China Vaccine Market Report, 2007-2009 China is the largest vaccine producer and consumer in the world. According to the statistics of the General Administration of Cust Table of contents List of tables / figures |
2008 |
2.000,00$ |
The Global Anti-Addiction Market, 2008-2023 Exclusive visiongain interviews with key opinion leaders in the addiction industry
/ Examination of a wealth of secondary sources Table of contents List of tables / figuresExtract |
2008 |
3.000,00$ |
The Japanese Pharmaceutical Market 2008-2023 Biennial National Health Insurance drug price reductions
/ Increasing R&D expenses
/ Intensifying competition between domestic c Table of contents List of tables / figuresExtract |
2008 |
3.000,00$ |
World Gastrointestinal Disorders Market 2008-2023 The current state of the world market for drugs to treat gastrointestinal disorders
/ Drivers and restraints
/ Opportunities and Table of contents List of tables / figuresExtract |
2008 |
3.000,00$ |
Oncology Market Leaders - Analyses and Outlook, Market Report 2008-2023 The oncology market will continue to generate high revenues and significant profitability in the years ahead, visiongain concludes Table of contents List of tables / figuresExtract |
2008 |
3.000,00$ |
China Vitamin Market Report, 2007-2008 The period from 2003 to the end of 2006 had witnessed the rapid development of Chinese vitamin manufacturers, they had together pl Table of contents List of tables / figures |
2008 |
2.500,00$ |
Outsourcing for contract manufacturing services 2008-2023 The revenue for world contract manufacturing business in 2007 was approximately $30bn, with a growth rate of 6% from 2006. The tec Table of contents List of tables / figuresExtract |
2008 |
3.000,00$ |
Alcon Inc.: PharmaVitae Profile This analysis examines the historical and forecast performance for Alcon in the prescription pharmaceutical sector. The profile en Table of contents List of tables / figures |
2008 |
5.700,00$ |
F. Hoffmann-La Roche Ltd.: PharmaVitae Profile This analysis examines the historical and forecast performance for Roche in the prescription pharmaceutical sector. The profile en Table of contents List of tables / figures |
2008 |
5.700,00$ |
Nycomed A/S: PharmaVitae Profile This analysis examines the historical and forecast performance for Nycomed in the prescription pharmaceutical sector. The profile Table of contents List of tables / figures |
2008 |
5.700,00$ |
Successful Pharmabiotech Alliance Strategies: Driving synergies, avoiding failure and managing relationships Driving synergies, avoiding failure and managing relationships
""The average value of pharma-biotech deals will almost treble by Table of contents List of tables / figures |
2008 |
3.835,00$ |
The CNS Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities ""The global CNS disorders market expanded by 8.0% from 2006, to reach total sales of $77.3bn in 2007. This growth has been primar Table of contents List of tables / figures |
2008 |
3.835,00$ |
The Future of RNAi Therapeutics: Drug Pipelines and Prospects ""The total RNAi therapy market is estimated to value $580m by 2012. This forecast is based upon current treatments, levels of mar Table of contents List of tables / figures |
2008 |
3.835,00$ |
Pharmaceuticals - Russia Pharmaceutical production in Russia
/ Pharmaceutical import in Russia
/ Pharmaceutical drug prices in Russia
/ Pharmaceutical r Table of contents List of tables / figures |
2008 |
590,00€ |
Global Orthopedics Contains an executive summary and data on value, volume and/or segmentation / / Provides textual analysis of the industry’s rece Table of contents List of tables / figures |
2008 |
250,00$ |
Orthopedics in Asia-Pacific Contains an executive summary and data on value, volume and/or segmentation / / Provides textual analysis of the industry’s rece Table of contents List of tables / figures |
2008 |
250,00$ |
Orthopedics in Europe Contains an executive summary and data on value, volume and/or segmentation / / Provides textual analysis of the industry’s rece Table of contents List of tables / figures |
2008 |
250,00$ |
Orthopedics in France Contains an executive summary and data on value, volume and/or segmentation / / Provides textual analysis of the industry’s rece Table of contents List of tables / figures |
2008 |
250,00$ |
Orthopedics in Germany Contains an executive summary and data on value, volume and/or segmentation / / Provides textual analysis of the industry’s rece Table of contents List of tables / figures |
2008 |
250,00$ |
Orthopedics in Japan Contains an executive summary and data on value, volume and/or segmentation / / Provides textual analysis of the industry’s rece Table of contents List of tables / figures |
2008 |
250,00$ |
Orthopedics in the United Kingdom Contains an executive summary and data on value, volume and/or segmentation / / Provides textual analysis of the industry’s rece Table of contents List of tables / figures |
2008 |
250,00$ |
Orthopedics in the United States Contains an executive summary and data on value, volume and/or segmentation / / Provides textual analysis of the industry’s rece Table of contents List of tables / figures |
2008 |
250,00$ |
The Pharmaceutical Wholesale and Distribution Industry Outlook & Analysis 2008 Discussion of the current W&D market
/ Forecast of the big three US wholesalers from 2008-2013
/ Drivers and restraints facing t Table of contents Extract |
2008 |
6.000,00$ |
The World OTC Pharmaceutical Market Analysis & Forecasts, 2008-2023 In particular, this report concentrates on the following essential aspects of the global OTC industry:
/
/ Major therapeutic ar Table of contents List of tables / figuresExtract |
2008 |
3.000,00$ |
United Kingdom Surgical Equipment Investment Opportunities, Analysis and Forecasts to 2012 The report provides surgical equipment information broken down into detailed categories and segments in United Kingdom.
/ Total Table of contents List of tables / figures |
2008 |
3.000,00$ |